EBR Systems, Inc.

Equities

EBR

AU0000182552

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 01:56:38 2024-05-01 am EDT			5-day change	1st Jan Change
0.9 ^AUD	-4.26%		+1.69%	+47.54%

Apr. 26	Australian Shares Fall on Fading Rate Cut Hopes; BHP Slips 4% on Anglo American Bid Update	MT
Apr. 26	EBR Systems on Track to Submit Cardiac Pacing Technology's Final Module to US FDA in Q3	MT

EBR Systems, Inc. Announces Study of WiSE Published in Heart Rhythm Journal

August 09, 2022 at 08:21 pm EDT

EBR Systems, Inc. announced that a scientific paper describing the use of leadless septal left ventricle (LV) pacing with the WiSE®-CRT system has been published in the leading peer-reviewed journal Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society and the Paediatric & Congenital Electrophysiology Society.

Latest news about EBR Systems, Inc.

Australian Shares Fall on Fading Rate Cut Hopes; BHP Slips 4% on Anglo American Bid Update	Apr. 26	MT
EBR Systems on Track to Submit Cardiac Pacing Technology's Final Module to US FDA in Q3	Apr. 26	MT
EBR Systems, Inc.(ASX:EBR) added to S&P/ASX All Ordinaries Index	Mar. 17	CI
EBR Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
1,104,030 Warrants of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.	Nov. 23	CI
11,546,742 Options of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.	Nov. 23	CI
5,785,188 CHESS Depositary Interests of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 24-NOV-2023.	Nov. 23	CI
EBR Systems, Inc. Announces Positive Results from First-In-Human Fully Leadless CRT in the US, Published in the Journal of the American College of Cardiology	23-10-25	CI
Ebr Systems, Inc. Announces Chief Financial Officer Changes	23-09-10	CI
EBR Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Eletrobras Says Wilson Ferreira Junior Resigned	23-08-15	MT
EBR Systems Draws Down Second Tranche of AU$30 Million Under Growth Capital Facility	23-07-03	MT
EBR Systems Opens Up to AU$5 Million Securities Purchase Plan	23-06-29	MT
EBR Systems Raises AU$30 Million to Expand Sales Team, Fund FDA Approval; Shares Down 6%	23-06-23	MT
EBR Systems Unlocks Second Tranche of AU$30 Million Under Growth Capital Facility	23-06-05	MT
Ebr Systems' Pivotal Solve-Crt Trial Meets Endpoints	23-05-22	CI
EBR Systems Says No Exposure to Silicon Valley Bank Collapse	23-03-12	MT
EBR Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
EBR Systems Appoints Chief Scientific Officer	23-02-21	MT
EBR Systems, Inc. Appoints Dr. Rick Kuntz as Consulting Chief Scientific Officer	23-02-21	CI
550,181 CHESS Depositary Interests of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 18-NOV-2022.	22-11-17	CI
EBR Systems, Inc. Provides an Update Regarding the Wise System	22-10-20	CI
3,063,365 Warrants of EBR Systems, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2022.	22-10-02	CI
EBR Systems, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-28	CI
EBR Systems Validates Efficacy of Cardiac Pacing Device; Shares Fall 3%	22-08-10	MT

Chart EBR Systems, Inc.

Duration

Period

More charts

Company Profile

EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.5846 USD

Average target price

0.9253 USD

Spread / Average Target

+58.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EBR SYSTEMS, INC.	+47.54%	188M
THERMO FISHER SCIENTIFIC	+8.11%	217B
DANAHER CORPORATION	+6.29%	183B
INTUITIVE SURGICAL, INC.	+10.92%	131B
BOSTON SCIENTIFIC CORPORATION	+24.71%	106B
SIEMENS HEALTHINEERS AG	-0.95%	62.16B
EDWARDS LIFESCIENCES CORPORATION	+10.69%	51.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.81%	50.89B
AGILENT TECHNOLOGIES, INC.	-0.40%	40.16B
GE HEALTHCARE TECHNOLOGIES INC.	+1.40%	34.79B

Other Advanced Medical Equipment & Technology